LZTS2 Antibody (C-term) (Cat. #AP13002b) western blot analysis in WiDr cell line lysates (35ug/lane).This demonstrates the LZTS2 antibody detected the LZTS2 protein (arrow).
Negative regulator of katanin-mediated microtubule severing and release from the centrosome. Required for central spindle formation and the completion of cytokinesis. May negatively regulate axonal outgrowth by preventing the formation of microtubule bundles that are necessary for transport within the elongating axon. Negative regulator of the Wnt signaling pathway Represses beta-catenin-mediated transcriptional activation by promoting the nuclear exclusion of beta-catenin
Tissue Specificity
Highly expressed in prostate and testis, and at slightly lower levels in spleen, thymus, uterus, small intestine and colon
Cellular Localization
Cytoplasm. Cytoplasm, cytoskeleton, centrosome. Note=Localized to the centrosome throughout the cell cycle. Localized to the midbody in cells undergoing cytokinesis
LZTS2 Antibody (C-term) (Cat. #AP13002b) western blot analysis in WiDr cell line lysates (35ug/lane).This demonstrates the LZTS2 antibody detected the LZTS2 protein (arrow).
Application Notes
WB:1:100~500
Additional Information
Form
Liquid
Storage Instructions
For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Storage Buffer
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.